Citation Impact
Citing Papers
Hallmarks of Cancer: The Next Generation
2011 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Comparison of infrared-excited up-converting phosphors and europium nanoparticles as labels in a two-site immunoassay
2007
Effects of season and dietary ascorbic acid on some biochemical characteristics of rainbow trout (Oncorhynchus mykiss) semen
1996
Acute kidney injury
2012 Standout
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
DNA‐Coated AFM Cantilevers for the Investigation of Cell Adhesion and the Patterning of Live Cells
2008 StandoutNobel
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Taking advantage of luminescent lanthanide ions
2005 Standout
Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD
2008
Advances in glomerular filtration rate-estimating equations
2010
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
2005 Standout
Standardization of Cystatin C: Development of primary and secondary reference preparations
2008
Kidney function estimating equations: where do we stand?
2006
Concentration of enzymatically active prostate‐specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models
2001
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients
2003
Cells on chips
2006 StandoutNature
Prostate specific antigen: biology, biochemistry and available commercial assays
2001
Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study
1996
ACR Appropriateness Criteria® on Renal Failure
2014
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
New Equations to Estimate GFR in Children with CKD
2009 Standout
Inhibition of Acrosin by Serpins. A Suicide Substrate Mechanism
1995
In Vivo activity of a PSA-activated doxorubicin prodrug against PSA-producing human prostate cancer xenografts
2000
Bioassay of prostate-specific antigen (PSA) using microcantilevers
2001
Colorimetric platform for visual detection of cancer biomarker based on intrinsic peroxidase activity of graphene oxide
2011
Chronic kidney disease: global dimension and perspectives
2013 Standout
A combined approach to data mining of textual and structured data to identify cancer-related targets
2006
Changes of Serum Calcium, Magnesium and Parathyroid Hormone Induced by Hemodialysis with Citrate-Enriched Dialysis Solution
2015
Development of a Novel Recombinant Serpin with Potential Antithrombotic Properties
1995
Determination of the production rate and non‐renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans
2005
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Mechanisms of Bone Metastasis
2004 Standout
Prevalence of Chronic Kidney Disease in the United States
2007 Standout
A strategy for sensitivity and specificity enhancements in prostate specific antigen-α1-antichymotrypsin detection based on surface plasmon resonance
2005
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Prostate-specific antigen
2000
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
2005 Standout
Chronic Kidney Disease
2016 Standout
Analytical performance of the Roche total and free PSA assays on the Elecsys 2010 immunoanalyzer
2002
Enhancement of sensitivity using hybrid stimulus for the diagnosis of prostate cancer based on polydiacetylene (PDA) supramolecules
2010
Early detection of acute renal failure by serum cystatin C
2004
Protein C Inhibitor Is a Potent Inhibitor of the Thrombin-Thrombomodulin Complex
1995
Cystatin C and NT‐proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10‐year study in primary care
2009 StandoutNobel
Interaction of activated protein C with serpins
1993
Functional Nucleic Acid Sensors
2009 Standout
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen.
1997
Serpin Structure, Mechanism, and Function
2002 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Lanthanide Luminescence for Biomedical Analyses and Imaging
2010 Standout
PD Fluids Contain High Concentrations of Cytotoxic GDPs Directly after Sterilization
2004
Synthesis and Characterization of a Novel Prostate Cancer-Targeted Phosphatidylinositol-3-kinase Inhibitor Prodrug
2012
Design, Synthesis, and Proposed Active Site Binding Analysis of Monocyclic 2-Azetidinone Inhibitors of Prostate Specific Antigen
2001
Time-Resolution in Fluorometry Technologies, Labels, and Applications in Bioanalytical Assays
2001
A Strategy for the Selective Imaging of Glycans Using Caged Metabolic Precursors
2010 StandoutNobel
How to Avoid Glucose Degradation Products in Peritoneal Dialysis Fluids
2006
Femtomolar Detection of Prostate-Specific Antigen: An Immunoassay Based on Surface-Enhanced Raman Scattering and Immunogold Labels
2003
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum
1995
Cancer incidence and risk factors after solid organ transplantation
2009
The Proportion of Prostate-specific Antigen (PSA) Complexed to α1-Antichymotrypsin Improves the Discrimination between Prostate Cancer and Benign Prostatic Hyperplasia in Men with a Total PSA of 10 to 30 μg/L
2002
Conserved regulation of the lymphocyte-specific expression oflckin the Fugu and mammals
2002 StandoutNobel
Electrochemiluminescence (ECL)
2004 Standout
Piezoelectric Nanogenerators Based on Zinc Oxide Nanowire Arrays
2006 StandoutScience
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
ENSAM: Europium Nanoparticles for Signal Enhancement of Antibody Microarrays on Nanoporous Silicon
2008
The Serpin MNEI Inhibits Elastase-like and Chymotrypsin-like Serine Proteases through Efficient Reactions at Two Active Sites
2001
Artificial Molecular Machines
2015 Standout
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
2020 Standout
Inhibition of Prostate-Specific Antigen (PSA) by α1-Antichymotrypsin: Salt-Dependent Activation Mediated by a Conformational Change
2002
Upconversion Luminescent Materials: Advances and Applications
2014 Standout
Rapid Inhibition of the Sperm Protease Acrosin by Protein C Inhibitor
1994
Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy
2012 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Lanthanide-Based Luminescent Hybrid Materials
2009 Standout
Prostate Specific Antigen Cleaves Parathyroid Hormone-Related Protein in the PTH-like Domain: Inactivation of PTHrP-Stimulated cAMP Accumulation in Mouse Osteoblasts
1996
Nanostructures in Biodiagnostics
2005 Standout
Prostate-specific antigen: biochemistry, analytical methods, and clinical application
1993
Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity
1994
Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios
1995
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Supersensitive Time-resolved Immunofluorometric Assay of Free Prostate-specific Antigen with Nanoparticle Label Technology
2001
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Modulation of Recombinant Human Prostate-Specific Antigen: Activation by Hofmeister Salts and Inhibition by Azapeptides Appendix: Thermodynamic Interpretation of the Activation by Concentrated Salts
2001
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
Works of Anders Christensson being referenced
Serum Cystatin C Is a More Sensitive and More Accurate Marker of Glomerular Filtration Rate than Enzymatic Measurements of Creatinine in Renal Transplantation
2003
Normalization of haemoglobin concentration with recombinant erythropoietin has minimal effect on blood haemostasis
2001
Increase in percent free prostate-specific antigen in men with chronic kidney disease
2008
Complex formation between protein C inhibitor and prostate‐specific antigen in vitro and in human semen
1994
Renovascular Disease and Renal Insufficiency - Diagnosis and Treatment
1999
Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitors
1990
Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products
2001
Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.
1992
Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility
2013
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
1991
The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer
1999
Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex
1995
Simple Cystatin C–Based Prediction Equations for Glomerular Filtration Rate Compared with the Modification of Diet in Renal Disease Prediction Equation for Adults and the Schwartz and the Counahan–Barratt Prediction Equations for Children
2005
Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer
1993
Different elimination patterns of β‐trace protein, β2‐microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration
2008